Literature DB >> 12729745

The tertiary structure and backbone dynamics of human prolactin.

Camille Keeler1, Priscilla S Dannies, Michael E Hodsdon.   

Abstract

Human prolactin is a 199-residue (23 kDa) protein closely related to growth hormone and placental lactogen with properties and functions resembling both a hormone and a cytokine. As a traditional hormone, prolactin is produced by lactotrophic cells in the pituitary and secreted into the bloodstream where it acts distally to regulate reproduction and promote lactation. Pituitary cells store prolactin in secretory granules organized around large prolactin aggregates, which are produced within the trans layer of the Golgi complex. Extrapituitary prolactin is synthesized by a wide variety of cells but is not stored in secretory granules. Extrapituitary prolactin displays immunomodulatory activities and acts as a growth factor for cancers of the breast, prostate and tissues of the female reproductive system. We have determined the tertiary structure of human prolactin using three-dimensional (3D) and four-dimensional (4D) heteronuclear NMR spectroscopy. As expected, prolactin adopts an "up-up-down-down" four-helical bundle topology and resembles other members of the family of hematopoietic cytokines. Prolactin displays three discrete structural differences from growth hormone: (1) a structured N-terminal loop in contact with the first helix, (2) a missing mini-helix in the loop between the first and second helices, and (3) a shorter loop between the second and third helices lacking the perpendicular mini-helix observed in growth hormone. Residues necessary for functional binding to the prolactin receptor are clustered on the prolactin surface in a position similar to growth hormone. The backbone dynamics of prolactin were investigated by analysis of 15N NMR relaxation phenomena and demonstrated a rigid four-helical bundle with relatively mobile interconnecting loops. Comparison of global macromolecular tumbling at 0.1mM and 1.0mM prolactin revealed reversible oligomerization, which was correlated to dynamic light scattering experiments. The existence of a reversible oligomerization reaction in solution provides insight into previous results describing the in vitro and in vivo aggregation properties of human prolactin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729745     DOI: 10.1016/s0022-2836(03)00367-x

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

Review 1.  Is there structural specificity in the reversible protein aggregates that are stored in secretory granules?

Authors:  Camille Keeler; Michael E Hodsdon; Priscilla S Dannies
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

2.  Obligate ordered binding of human lactogenic cytokines.

Authors:  Jeffery L Voorhees; Charles L Brooks
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

3.  Lactogens and estrogens in breast cancer chemoresistance.

Authors:  Gila Idelman; Eric M Jacobson; Traci R Tuttle; Nira Ben-Jonathan
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

4.  Structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity.

Authors:  Edward T Petri; Andjelka Celic; Scott D Kennedy; Barbara E Ehrlich; Titus J Boggon; Michael E Hodsdon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

5.  Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis.

Authors:  Jaeok Lee; Syamantak Majumder; Suvro Chatterjee; Kambadur Muralidhar
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

6.  Concentration-dependent staining of lactotroph vesicles by FM 4-64.

Authors:  Matjaz Stenovec; Igor Poberaj; Marko Kreft; Robert Zorec
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

7.  Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.

Authors:  John F Langenheim; Dunyong Tan; Ameae M Walker; Wen Y Chen
Journal:  Mol Endocrinol       Date:  2005-11-03

8.  Structure and function of a new class of human prolactin antagonists.

Authors:  Laura DePalatis; Colleen M Almgren; Jypji Patmastan; Mark Troyer; Todd Woodrich; Charles L Brooks
Journal:  Protein Expr Purif       Date:  2009-02-21       Impact factor: 1.650

9.  Contribution of individual histidines to the global stability of human prolactin.

Authors:  Camille Keeler; M Cristina Tettamanzi; Syrus Meshack; Michael E Hodsdon
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

10.  Analysis of site-specific histidine protonation in human prolactin.

Authors:  M Cristina Tettamanzi; Camille Keeler; Syrus Meshack; Michael E Hodsdon
Journal:  Biochemistry       Date:  2008-07-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.